UNCY
Unicycive Therapeutics Inc.
$5.72
+$0.20(+3.62%)
69
Overall
75
Value
63
Tech
--
Quality
Market Cap
$79.48M
Volume
252.85K
52W Range
$3.71 - $11.00
Target Price
$44.14
Company Overview
| Mkt Cap | $79.48M | Price | $5.72 |
| Volume | 252.85K | Change | +3.62% |
| P/E Ratio | -2.2 | Open | $5.54 |
| Revenue | -- | Prev Close | $5.52 |
| Net Income | $-36.7M | 52W Range | $3.71 - $11.00 |
| Div Yield | N/A | Target | $44.14 |
| Overall | 69 | Value | 75 |
| Quality | -- | Technical | 63 |
No chart data available
Latest News
Unicycive Therapeutics Doubles Stock Sale Agreement
TipRanks Auto-Generated Newsdesk•12 days ago
Unicycive Therapeutics (UNCY) Gets a Buy from Noble Financial
TipRanks Auto-Generated Intelligence Newsdesk•13 days ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), United Therapeutics (UTHR) and Unicycive Therapeutics (UNCY)
Brian Anderson•a month ago
Guggenheim Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | UNCY | $5.72 | +3.6% | 252.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Unicycive Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW